The Evolution of STI Testing: A Catalyst for Modern Diagnostic Technologies
HIV Diagnostic Algorithms: Balancing Sensitivity and Specificity The World Health Organization (WHO) and U.S. Centers for Disease Control and Prevention (CDC) have guidelines for HIV diagnosis that rely on a structured algorithm that combines multiple tests to maximize accuracy. These algorithms follow a common principle: screen with a highly sensitive initial assay and confirm reactive results with a different test that is both sensitive and highly specific.
missing the early viremic phase when viral load and transmission risk are highest. 10 This delay limited opportunities for early diagnosis and intervention, when prevention and treatment are most effective. To close this gap, nucleic acid amplification tests (NAATs) were introduced, which detect HIV RNA within 10–14 days of exposure, before antibodies or p24 antigen appear. 10 Since its adoption, molecular testing for HIV has become increasingly valuable in confirming early infection, particularly in newborn screening, blood donations and acute exposure cases. Recent advances have made molecular testing faster and more automated, and several assays
Until 2014, the U.S. Public Health Service HIV testing algorithm, originally established in the late 1980s, recommended confirmatory Western blot testing following a positive screening result. 2 Although the Western blot offers high specificity, it detects infection about 5 weeks after exposure,
TECHNOLOGICAL ADVANCEMENTS IN HIV DIAGNOSTIC TESTING
DESCRIPTION DIAGNOSTIC TECHNIQUE
TIME PERIOD
Detects HIV antibodies in blood samples, providing first lab-based serological test for HIV
Early 1980s
ELISA
Confirmatory test for HIV, identifying specific HIV proteins via antibody binding
Mid-1980s
Western Blot
Identifies HIV DNA/RNA in blood; especially valuable in early detection and viral load assessment
1990s
PCR
Quantifies HIV viral load in blood to monitor treatment effectiveness and disease progression
Early 2000s
qPCR
Quick detection of HIV antibodies using fingerstick blood or oral fluids, e.g. OraQuick HIV test
Early 2000s
Rapid Antibody Tests
Directly detects HIV RNA in blood, useful for early detection and confirmation
2000s
NAT (Nucleic Acid Testing)
Late 2000s - present High-throughput sequencing allowing detailed HIV genetic analysis, detecting drug resistance and viral diversity
NGS
2010s Combines HIV antibody & antigen detection to increase sensitivity, identifying both acute and chronic infections
Multiplex Testing
Miniaturized diagnostics integrating multiple assays for rapid POC HIV testing, e.g. CD4+ counts Lab-on-a-Chip & Microfluidics
2010s - present
Detects HIV antigens/antibodies or nucleic acids with portable sensors for POC, enabling rapid results
2010s - present
Biosensors
Gene-editing technology adapted to detect HIV nucleic acids with high sensitivity, e.g. SHERLOCK assay
2016 - present
CRISPR-Based Diagnostics
Analyzes large genomic datasets to predict HIV drug resistance patterns, optimizing treatment regimens
2020s - present
Machine Learning & AI
Figure 4. Technological Advancements in HIV Diagnostic Testing This table summarizes key milestones in HIV diagnostic development, outlining major technological innovations and their approximate introduction dates, to trace the evolution from first-generation EIAs to modern molecular and self-testing platforms. Adapted from: Afzal, M., et al. (2025). Innovative diagnostic approaches and challenges in the management of HIV: Bridging basic science and clinical practice. Life , 15 (2), 209. https://doi.org/10.3390/life15020209
GENengnews.com | 31
Powered by FlippingBook